(Q44590786)

4 December 2017

title

Substance P regulates Th1-type colitis in IL-10 knockout mice (English)

1 reference

4 December 2017

Substance P Regulates Th1-Type Colitis in IL-10 Knockout Mice (English)

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3762

12 March 2024

0 references

0 references

1 reference

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3762

12 March 2024

4

David Elliott

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14500676

12 March 2024

5

Nigel Bunnett

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14500676

12 March 2024

author name string

Arthur Blum

2

1 reference

4 December 2017

Ahmed Metwali

3

1 reference

4 December 2017

Razvan Arsenescu

6

1 reference

4 December 2017

Joel V. Weinstock

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14500676

12 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

4 December 2017

published in

Journal of Immunology

1 reference

4 December 2017

volume

171

1 reference

4 December 2017

issue

7

1 reference

4 December 2017

page(s)

3762-3767

1 reference

Neurokinin-1 (NK-1) receptor is required in Clostridium difficile- induced enteritis

4 December 2017

cites work

4

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3762

Substance-P-mediated intestinal inflammation: inhibitory effects of CP 96,345 and SMS 201-995

12 March 2024

6

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3762

Localization of the neurokinin 1 (NK-1) receptor in the human antrum and duodenum

12 March 2024

7

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3762

Receptor binding sites for substance P, but not substance K or neuromedin K, are expressed in high concentrations by arterioles, venules, and lymph nodules in surgical specimens obtained from patients with ulcerative colitis and Crohn disease

12 March 2024

9

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3762

Neurokinin-1 receptor expression in inflammatory bowel disease: molecular quantitation and localisation

12 March 2024

10

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3762

Methods Used to Study Immunoregulation of Schistosome Egg Granulomas

12 March 2024

11

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3762

Constructing polycompetitor cDNAs for quantitative PCR (J. Immunol. Methods 165 (1993) 37-46).

12 March 2024

13

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3762

Constructing polycompetitor cDNAs for quantitative PCR (J. Immunol. Methods 165 (1993) 37-46; 173(1994) 133).

12 March 2024

14

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3762

Rapid development of colitis in NSAID-treated IL-10-deficient mice.

12 March 2024

15

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3762

Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice

12 March 2024

16

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3762

Dynamin and Rab5a-dependent trafficking and signaling of the neurokinin 1 receptor

12 March 2024

17

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3762

Lessons from genetically engineered animal models. XII. IL-10-deficient (IL-10(-/-) mice and intestinal inflammation

12 March 2024

20

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3762

Control of intestinal inflammation by regulatory T cells

12 March 2024

21

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3762

Interleukin-10 and the interleukin-10 receptor

12 March 2024

22

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3762

Mechanisms of interleukin-10-mediated immune suppression

12 March 2024

23

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3762

Substance P diminishes lipopolysaccharide and interferon-gamma-induced TGF-beta 1 production by cultured murine macrophages

12 March 2024

26

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3762

IL-4 and IFN-gamma up-regulate substance P receptor expression in murine peritoneal macrophages

12 March 2024

27

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3762

Neutral endopeptidase (EC 3.4.24.11) terminates colitis by degrading substance P

12 March 2024

28

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3762

Deletion of neutral endopeptidase exacerbates intestinal inflammation induced by Clostridium difficile toxin A.

12 March 2024

29

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3762

Functional neurokinin 1 receptors for substance P are expressed by human vascular endothelium

12 March 2024

31

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3762

Effects of substance P on human colonic mucosa in vitro

12 March 2024

32

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3762

Differential expression of neurokinin-1 receptor by human mucosal and peripheral lymphoid cells

12 March 2024

34

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3762

Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis

12 March 2024

36

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3762

Hemokinin 1 is a full agonist at the substance P receptor

12 March 2024

37

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3762

Distribution and quantitation of gut neuropeptides in normal intestine and inflammatory bowel diseases

12 March 2024

38

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3762

Abnormal neuropeptide concentration in rectal mucosa of patients with inflammatory bowel disease

12 March 2024

40

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3762

Colonic substance P levels are increased in ulcerative colitis and decreased in chronic severe constipation

12 March 2024

41

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3762

Changes in substance P-immunoreactive innervation of human colon associated with ulcerative colitis

12 March 2024

43

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3762

Substance P containing nerve fibers in rectal mucosa of ulcerative colitis

12 March 2024

44

1 reference

https://api.crossref.org/works/10.4049/JIMMUNOL.171.7.3762

12 March 2024

Identifiers

1 reference

4 December 2017

1 reference